Distinguished in Properdin Deficiency

Marina Noris

Science And Technology Park Kilometro Rosso, 
Bergamo, IT 
Distinguished in Properdin Deficiency
Science And Technology Park Kilometro Rosso, 
Bergamo, IT 
OverviewLocationsClinical Research

Overview

Marina Noris practices in Bergamo, Italy. Ms. Noris is rated as a Distinguished expert by MediFind in the treatment of Properdin Deficiency. Her top areas of expertise are D-Plus Hemolytic Uremic Syndrome, Hemolytic-Uremic Syndrome, D-Minus Hemolytic Uremic Syndrome, Membranoproliferative Glomerulonephritis, and Kidney Transplant.

Her clinical research consists of co-authoring 121 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 4 articles in the study of Properdin Deficiency.

Gender
Female

Locations

Science And Technology Park Kilometro Rosso, Bergamo, Italy
Other Locations
Ranica, Italy
Milan, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Pilot Study to Explore the Efficacy and Safety of Rescue Theraphy With Antibodies From Convalescent Patients Obtained With Double -Filtration Plasmapheresis (DFPP) and Infused in Critically Ill Ventilated Patients With Coronavirus Disease 2019 (COVID-19)
A Pilot Study to Explore the Efficacy and Safety of Rescue Theraphy With Antibodies From Convalescent Patients Obtained With Double -Filtration Plasmapheresis (DFPP) and Infused in Critically Ill Ventilated Patients With Coronavirus Disease 2019 (COVID-19)
Enrollment Status: Terminated
Publish Date: March 23, 2023
Intervention Type: Biological
Study Phase: Not Applicable
A Pilot Study to Explore the Efficacy and Safety of Rescue Therapy With Antibodies From Convalescent Patients Obtained With Double-filtration Plasmapheresis (DFPP) and Infused in Patients With Coronavirus Disease 2019 (COVID-19) and Need of Oxygen Support Without Mechanical Ventilation
A Pilot Study to Explore the Efficacy and Safety of Rescue Therapy With Antibodies From Convalescent Patients Obtained With Double-filtration Plasmapheresis (DFPP) and Infused in Patients With Coronavirus Disease 2019 (COVID-19) and Need of Oxygen Support Without Mechanical Ventilation
Enrollment Status: Withdrawn
Publish Date: September 23, 2022
Intervention Type: Biological
Study Phase: Not Applicable
View 1 Less Clinical Trial

121 Total Publications

C3d-targeted complement inhibitors to correct complement dysregulation in aHUS patients.
C3d-targeted complement inhibitors to correct complement dysregulation in aHUS patients.
Journal: Frontiers in immunology
Published: April 30, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Noris's expertise for a condition
ConditionClose
View All 16 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile